{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:08:35Z","timestamp":1782169715520,"version":"3.54.5"},"reference-count":15,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Use of amphotericin B-impregnated bone cement in combination with systemic antifungals for the treatment of coccidioidal osteomyelitis offers the potential for sustained local concentrations of drug at the site of the infection. Amphotericin B levels in bone of up to 5.1 \u03bcg\/g have been demonstrated 4 months after placement of bone cement.<\/jats:p>","DOI":"10.1128\/aac.00963-13","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T04:42:13Z","timestamp":1378269733000},"page":"6341-6343","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Amphotericin B-Impregnated Bone Cement To Treat Refractory Coccidioidal Osteomyelitis"],"prefix":"10.1128","volume":"57","author":[{"given":"Elizabeth S.","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, University of California\u2014Davis, Davis, California, USA"},{"name":"Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kreulen","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Giza","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.00574"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2009.02.001"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-9-200011070-00009"},{"key":"e_1_3_1_5_2","first-page":"383","article-title":"Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans","volume":"44","author":"Marra F","year":"2001","unstructured":"MarraF RobbinsGM MasriBA DuncanC WasanKM KwongEH JewessonPJ. 2001. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can. J. Surg. 44:383\u2013386.","journal-title":"Can. J. Surg."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2012.04.034"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-010-1211-4"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-012-2317-4"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200301000-00006"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M143"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2006.09.013"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-1928-5"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.01982.x"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.408-410.2000"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2001.00338.x"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq039"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00963-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00963-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:30:19Z","timestamp":1645482619000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00963-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1128\/AAC.00963-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.00963-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"2013-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}